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Abstract: The neurotoxicity induced by the mitochondrial inhibitor 3-nitropropionic acid (3-NPA) is associated with a 
decrease of ATP synthesis and an increase of free radical production which can lead to apoptosis or necrosis. We have 
used the PC12, neuron-like rat pheochromocytoma cell line, to study further the mechanism of 3-NPA-evoked neurotoxic-
ity and the effects of acetyl-L-carnitine (ALC) which has neuroprotective actions against various types of mitochondrial 
inhibitors. 
Cultured PC 12 cells were exposed to a low dose of 3-NPA 50 (microM) in the presence or absence of 5 mM ALC. The 
dose of 3-NPA was sub toxic and no changes in pro-apoptotic Bax or anti-apoptotic Bcl-2 gene expression were observed. 
We followed specific genetic markers to look for changes evoked by 3-NPA toxicity and also changes associated with 
neuroprotection exerted by the ALC treatment, using RT-PCR arrays (delta-delta method). 3-NPA exposure evoked a  
decrease in expression of the Tp53 gene. This down regulation was prevented by pretreatment of the cells with ALC. The 
Tp53 gene responds to cellular stresses and the effects seen here are possibly associated with the 3-NPA evoked changes 
in mitochondrial metabolism. Other genes associated with stress and apoptosis, Parp-1, Bcl-2, and Bax were not affected 
by 3-NPA or ALC. The decrease of inflammatory response Il-10 gene expression due to 3-NPA was further lowered  
by presence of ALC. Other inflammation related genes, Il1rn, Nr3c1 and Cxcr4 were not affected. Interestingly, the  
glutamate transporter slc17a7, carnitine-acylcarnitine translocase Slc25a20 and heat shock proteins genes, Hsp27, Hmox1 
(Hsp32, HO1) as well as Hspa 1a (Hsp 70) increased only when both ALC and small dose of 3-NPA were present. The  
alterations in gene expression detected in this study suggest role of several intracellular pathways in the neurotoxicity of 
3-NPA and the neuroprotection against 3-NPA-induced neurotoxicity by ALC.  
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INTRODUCTION 
  The mitochondrial inhibitor, 3-nitropropionic acid (3-
NPA), induces cellular energy deficit through inactivation of 
electron transport chain complex II (succinate dehydro-
genase). A decrease of ATP synthesis and an increase of free 
radical production followed by apoptosis or necrosis caused 
by secondary excitotoxicity are major features of 3-NPA 
generated neurotoxicity [1]. These changes are associated 
with a decrease of body temperature and a decrease of do-
pamine production in susceptible brain regions in animal 
model of 3-NPA neurotoxicity [2, 3]. 3-NPA causes activa-
tion of NMDA receptors in dopaminergic, GABAergic and 
glutamatergic systems [1-4]. 
  The neuron-like rat pheochromocytoma cell line, PC12, 
has been used to study mechanism of neurotoxicity and   
neuroprotection in dopaminergic neurons [5, 6]. The single 
millimolar dose of 3-NPA results in apoptotic and necrotic 
death of PC12 cells [7]. The application of energy metabo-
lism enhancers such as acetyl-L-carnitine (ALC) or coenzyme  
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Q10, have been reported to prevent this neurotoxicity [8-12]. 
Endogenous L-carnitine is physiologically required for the 
transfer of free fatty acids across the mitochondrial mem-
brane for -oxidation but may also have a number of other 
functions ranging from osmolarity to effects on cellular 
membrane [13]. 
  Our earlier studies have focused on finding genetic mark-
ers of 3-NPA toxicity [14] and the possible genetic changes 
associated with neuroprotection by metabolic modifiers such 
as carnitines [9]. We reported previously an activation of 
uncoupling protein-2 gene in the rat striatum along with 
genes related to dopamine metabolism in response to 3-NPA, 
which was attenuated by L-carnitine pretreatment [8]. The 
present study was designed to investigate an effect of sub 
toxic doses of 3-NPA on expression of selected genes, repre-
senting pathways involved in metabolism of carnitine, glu-
tamate transport, apoptosis, heat shock, and inflammatory 
responses. The neuroprotective actions of ALC were investi-
gated as well. 
MATERIAL AND METHODS 
PC12 Culturing, Treatment and Harvest 
  The PC12 cell line (Pheochromocytoma cell line) was 
obtained from the American Type Culture Collection 196    Current Neuropharmacology, 2011, Vol. 9, No. 1  Virmani et al. 
(ATCC, Rockville, MD). The undifferentiated PC12 cells 
were grown in RPMI medium supplemented with 10% fetal 
bovine serum (Hyclone, Logan, USA). Cells were counted 
and seeded in 12 well dishes at concentration 0.75 x 10
6 cells 
per well in 2 ml medium. Cells were then treated with 50 
microM 3-NPA, 5 mM ALC or with combination of both 
and incubated for 24 hrs. After withdrawal of the media cells 
were washed with 1 ml of HBSS, followed by aspiration of 
the media and further incubation in 0.5 ml of trypsin solution 
for 2 min. 10 ml of RPMI-1640 was added, and solution was 
centrifuged. Cell pellets were frozen immediately in -80
oC.  
RNA Isolation and Real-time RT-PCR 
  Total RNA from each frozen cell pellet was isolated us-
ing RNAqueous - 4PCR, Ambion, Austin, TX. The integrity 
and purity of total RNA was determined with the RNA 
6000LabChip kit and Agilent 2100 Bioanalyzer (Agilent 
Technologies, Wilmington, DE) [14]. For each sample, 
cDNA was synthesized with random hexamers and 2 ug of 
total RNA using an iScript cDNA Synthesis Kit (Bio-Rad 
Laboratories, Inc., Hercules, CA). The cDNA was aliquoted 
and stored at -80
o C until use.  
  PCR primer sequences were designed using the NCBI 
genes database and the Taqman Probe and Primer Design 
function (ignoring the probe) of the Primer Express v 1.5 
software of Applied Biosystems (Applied Biosystems, Foster 
City, CA). All primers were synthesized by IDT, Inc 
(Coralville, IA). During the first step of analysis the samples 
in each of the 4 experimental groups were combined and CT 
was estimated using the 2-CT method [15]. This screen 
allowed selecting 16 pair of primers representing genes 
which transcripts are most likely being altered by the treat-
ments. 
 Table  1 contains sequences of 16 pairs of primers used 
for further quantification of transcripts. All real time PCR 
reactions were carried out using 2xSYBR Green Master Mix 
(iTaq SYBR Green Supermix with ROX, Bio-Rad Laborato-
ries, Inc., Hercules, CA) and the ABI Prism 7700 Sequence 
Detection System. Assay parameters (Table 2) were opti-
mized and relative gene expression was calculated using 
standard curves (log of the ng RNA-equivalents of cDNA 
versus cycle number) generated using 4-fold serial dilutions 
of cDNA. The cDNA was a pool of all cDNA’s prepared in 
this experiment. Data were normalized to 18 s ribosomal 
RNA. Values of expression presented in results figures are 
ng of each gene of interest per ng of 18 S relative to a stan-
dard curve for each gene of interest. 
Table 1.  Genes Analyzed in PC12 Cells 
Symbol Accession  #  Description 
Apoptosis 
Parp-1  NM_013063  poly(ADP-ribose) polymerase family, member 1 
Tp53 NM_030989  tumor  protein  p53 
Pdcd8 (AIF)  NM_031356  programmed cell death 8 
Bcl2  NM_016993  B-cell leukemia/lymphoma 2 
Bax  NM_017059  Bcl2-associated X protein 
Inflammation 
Il10 NM_012854  interleukin  10 
Il1rn  NM_022194  interleukin 1 receptor antagonist 
Nr3c1  NM_012576  nuclear receptor subfamily 3, group C, member 1 
Cxcr4 NM_022205  chemokine  (C-X-C  motif)  receptor  4 
Ptgs1 (Cox1)  NM_017043  prostaglandin-endoperoxidase synthase 1 
Transporters 
Slc17a7  NM_053859  solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 
Slc25a20  NM_053965  solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20 
Slc25a14 (ucp5)  NM_053501  solute carrier family 25 (mitochondrial carrier, brain), member 14 
Heat Shock Proteins 
Hsp27  M86389  heat shock protein 27 
Hmox1 (Hsp27,HO1)  NM_012580  heme oxygenase (decycling) 1 
Hspa 1a (Hsp70)  NM_031971  heat shock 70 kDa protein 1A Acetyl-L-Carnitine Modulates TP53 and IL10 Gene Expression Induced  Current Neuropharmacology, 2011, Vol. 9, No. 1    197 
Data Analysis 
  Nonparametric (Kruskal-Wallis Rank Sum Test) and 
parametric (t-Test) statistical tests were applied using   
SigmaStat statistical package (Systat Software, Inc. Rich-
mond, CA). Values of p<0.05 were considered statistically 
significant. 
RESULTS 
  ALC alone did not cause changes in genes expression 
(the 16 genes tested) in the PC12 cell culture. The significant 
differences in several genes expressions were observed   
between the control and 3-NPA and between control and   
3-NPA pretreated with ALC. The changes in the expression 
of the genes by the PC12 cells in response to 3-NPA alone or 
in the presence of the 3-NPA and ALC are summarized in 
Table 3. 
  The decrease in Tp53 gene expression in response to the 
3-NPA (50 microM) was abolished by the pretreatment of 
the PC12 cells with ALC (5 mM) (Table 3). In contrast the 
decrease in IL-10 gene expression in cells exposed to 3-NPA 
was further lowered by ALC “Fig. (1)”. The 3-NPA pro-
voked a significant increase in Ptgs1 (Cox1) gene expression 
which was increased by the presence of ALC but not signifi-
cantly “Fig. (2)”. Other genes related to inflammation, Il1rn, 
Nr3c1 and Cxcr4 were not affected by either 3-NPA or 3-
NPA plus ALC. Interestingly, the glutamate transporter 
slc17a7, carnitine-acylcarnitine translocase Slc25a20 and 
heat shock proteins genes, Hsp27, Hmox1 (Hsp32, HO1) and 
Hspa 1a (Hsp 70) increased only when both ALC and small 
dose of 3-NPA were present. 
DISCUSSION 
  The plant and fungal toxin, 3-NPA, acts as an inhibitor of 
mitochondrial function via irreversible inactivation of the 
mitochondrial inner membrane enzyme, succinate dehydro-
genase (SDH) [16]. Inhibition of SDH disturbs electron 
transport and leads to cellular energy deficits and neuronal 
injury. In the present study, we examined the effect of low 3-
NPA dose on expression of panel of selected genes, repre-
senting pathways involved in metabolism of carnitine, glu-
tamate transport, apoptosis, heat shock proteins and inflam-
matory responses. Our specific objective was to identify ge-
netic markers of neurotoxicity and neuroprotection which 
could eventually lead to discovery of new function or path-
ways for “old” genes and proteins. Cells were treated with 50 
M 3-NPA, 5 mM acetyl-L-carnitine (ALC) or combination 
of 3-NPA and ALC and incubated for 24 hrs. 
  We observed a decrease of Tp53 gene expression, which 
was abolished by pretreatment of the cells with ALC. The 
initiation of apoptosis is usually associated with an increase 
in the expression of Tp53. Activated Tp53 can translocate 
into nucleus and activate proapoptotic Bax. The decrease of 
expression of Tp53 might be related to other functions of this 
protein. The main function of Tp53 is to maintain genomic 
stability in the cell. 
  In genetic pathways of excitotoxicity, a decrease of Tp53 
activity can delay Ca
2++ induced apoptosis. Another mecha-
nism through which Tp53 could regulate apoptosis may in-
volve NAD
+-dependent histone deacetylases. The associa-
tion of human deacetylases SIRT1 with Tp53 results in 
deacetylation of Tp53. This further inhibits transcriptional 
Table 2.  Primers Used in Real Time RT-PCR SYBR Green Assay to Quantify Genes Expression in PC12 Cells 
Symbol   Accession #  5’ Primer  3’ Primer 
Parp-1 NM_013063  cctgacccttcggccag  caccagacggaatccctgtt 
Tp53 NM_030989  catgagcgttgctctgatgg  gatttccttccacccggataa 
Pdcd8 NM_031356  tgcgtccagaggccga  acgccattgctggaag 
Bcl2 NM_016993  gggacgctttgccacg cacaatcctcccccagttca 
Bax NM_017059  tccgtgtggcagctgacat  aagggcaaccacccgg 
Il10 NM_012854  tgcaacagctcagcgca  gtcacagctttcgagactggaa 
Il1rn NM_022194  gcgctttaccttcatccgc ctggacaggcaagtgattcga 
Nr3c1 NM_012576  gggaccacctcccaagct  caccccgtaatgacatcctga 
Cxcr4 NM_022205  ctgtggatggtggtgttcca  acgatgcccggcagg 
Ptgs1 NM_017043  gcccagttccagtatcgca  gcggatgccagtgatagagg 
Slc17a7 NM_053859  ccaatgtgcgaaagctgatgaa  acgcccttggagtgtgagta 
Slc25a20 cac  NM_053965  ccccttggacacggtcaa  ggtggctgcccaggc 
Slc25a14 ucp5  NM_053501 gccatgagatgtctggtctgaa  aactcggcaacaatagaggca 
Hsp27 M86389  cgatcgctggcgcg  ggtcttaactgtgagctcctcagg 
Hmox1 NM_012580  cgaaacaagcagaacccagtc  gcagcccttcggtgca 
Hspa 1a  NM_031971  caagaatgcgctcgagtcct  gctgatcttgcccttgagacc 198    Current Neuropharmacology, 2011, Vol. 9, No. 1  Virmani et al. 
activity of Tp53 and prevents apoptosis. SIR1 mediated 
deacetylation of Tp53 may lead to cell survival under meta-
bolic stress condition. The NAD
+ and histone deacetylases 
mediated anti-apoptotic action of Tp53 remains to be   
explored in the study of neuroprotective agents such as ALC. 
  A decrease of Il-10 gene expression after PC12 exposure 
to 3-NPA was further lowered by presence of ALC. The Il-
10 anti-inflammatory pathway plays an important role in the 
central nervous system by downregulating production of 
microglial proinflammatory signals. In the classical Il-10 
antiinflammatory signaling pathway, Il-10 interacts with Il-
10 receptor, which belongs to JAK/STAT class of receptors. 
Down regulation of Il-10 pathway found in PC12 cells (non-
inflammatory cell line) did not cause the downregulation of 
HO-1. This indicates possibility of other housekeeping func-
tion of Il-10 and activation of transcriptional regulators of 
HO-1 different from Il-10. There is also an intriguing possi-
bility of co-regulation of Cox1 and Il-10 which both are in-
volved in hypothermia regulation. In a mammal model of 
hypothermia, Il-10 secures normothermia. Hypothermia is a 















Fig. (1). Effect of 3-nitropropionic acid (3-NPA) and acetyl-L-
carnitine (ALC) on Il10 gene expression in PC12 cells.  Mean ± 
SEM. 
Table 3.  Effects of 3-NPA with and without Acetyl-L-Carnitine Pretreatment on Gene Expression in PC12 Cells 
GENES   3-NPA  Acetylcarnitine/3-NPA 
  Change  P values  Change   P values 
Apoptosis 
Parp-1        
Tp53  down  p = 0.009     
Pdcd8 (AIF)      up  p = 0.05 
Bcl2        
Bax        
Inflammation 
Il10  down  p = 0.024  down  p = 0.007 
Il1rn        
Nr3c1        
Cxcr4         
Ptgs1 (Cox1)  up p   0.001  up  p  0.001 
Transporters 
Slc17a7     up  p   0.001 
Slc25a20       up  p = 0.018 
Slc25a14 (ucp5)         
Heat Shock Proteins 
Hsp27     up  p   0.001 
Hmox1 ( Hsp32, HO1)      up  p = 0.024 














Fig. (2). Effect of 3-nitropropionic acid (3-NPA) and acetyl-L-
carnitine (ALC) on Ptgs1 (Cox1) gene expression in PC12 cells. 
Mean ± SEM. 
  Interestingly, the glutamate transporter vesicular gluta-
mate transporter (Slc17a7 gene), the carnitine-acylcarnitine 
translocase (Slc25a20) and the heat shock proteins genes 
(Hsp27, Hsp 32, Hsp70) increased only when both ALC and 
small dose of 3-NPA were present. The increase of transcrip-
tion of vesicular glutamate transporter gene may represent 
protective response to metabolic stress. The increase in ex-
pression of the acyl-carnitine –carnitine exchanger would 
have effects on mitochondrial metabolism and the role of the 
increased expression of both Slc17a7 and Slc25a20 genes in 
the possible neuroprotective action against 3-NPA needs to 
be studied further. With regards to the heat shock proteins, 
they have been implicated in multiple functions in cellular 
stress conditions. 
  In summary, the gene expression alterations seen in the 
present study suggest role of several intracellular pathways 
in the neurotoxicity of 3-NPA and the neuroprotection by 
ALC. These changes probably reflect the “remodeling” of 
gene expression to maintain cell energy status [17]. Further 
in vivo studies are necessary to compare the sub-lethal and 
lethal doses of the 3-NPA and the effects of other putative 
neuroprotective agents. 
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